Three-year Mortality Reduced in Medicare Beneficiaries with HF Following ICD Implantation

Cardiology Today -- Patients with HF and left ventricular ejection fraction <35% who received an implantable cardioverter defibrillator during hospitalization had better survival at three years than those who received no device.